Unusual course of Lafora diseaseZutt, R., Drost, G., Vos, Y., Elting, J. W., Miedema, I., tijssen, M. A., Brouwer, O. & de Jong, B. M., Dec-2016, In : epilepsia open. 1, 3-4, p. 136-139 4 p.
Research output: Contribution to journal › Article › Academic › peer-review
A 42-year-old male was admitted for refractory status epilepticus. At the age of 25, he had been diagnosed with juvenile myoclonic epilepsy. He had a stable clinical course for over a decade until a recent deterioration of behavior and epilepsy. After exclusion of acquired disorders, diagnostic work-up included application of next-generation sequencing (NGS), with a gene panel targeting progressive myoclonic epilepsies. This resulted in the diagnosis Lafora disease resulting from compound heterozygous NHLRC1 pathogenic variants. Although these pathogenic variants may be associated with a variable phenotype, including both severe and mild clinical course, the clinical presentation of our patient at this age is very unusual for Lafora disease. Our case expands the phenotype spectrum of Lafora disease resulting from pathogenic NHLRC1 variants and illustrates the value of using NGS in clinical practice to lead to a rapid diagnosis and guide therapeutic options
|Number of pages||4|
|Early online date||25-Aug-2016|
|Publication status||Published - Dec-2016|
No data available